Kolexia
Muller Etienne
Pharmacien
Centre François-Baclesse
Caen, France
26 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de l'ovaire Tumeurs de la prostate Syndrome du côlon irritable Instabilité du génome Tumeurs du sein Prédisposition génétique à une maladie Chondrosarcome Tumeurs du col de l'utérus Hypersensibilité

Industries

AstraZeneca
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.
Therapeutic advances in urology   28 février 2024
Validation of the Clinical Use of GIScar, an Academic-developed Genomic Instability Score Predicting Sensitivity to Maintenance Olaparib for Ovarian Cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research   02 novembre 2023
Development of genomic instability score for ovarian cancers from a limited panel of genes
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference   01 mai 2023
SPiP: Splicing Prediction Pipeline, a machine learning tool for massive detection of exonic and intronic variant effects on mRNA splicing.
Human mutation   20 novembre 2022
Standardisation of pathogenicity classification for somatic alterations in solid tumours and haematologic malignancies.
European journal of cancer (Oxford, England : 1990)   23 octobre 2021
Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
American journal of human genetics   30 septembre 2021
PRO-CARBO: Multicentre, Open-label Phase 2 Trial Evaluating the Efficacy of CARBOPLATIN in Metastatic Prostate Cancer With Gene Alterations in the Homologous Recombination Pathway
Essai Clinique (Centre François-Baclesse)   28 avril 2021
SpliceLauncher: a tool for detection, annotation and relative quantification of alternative junctions from RNAseq data.
Bioinformatics (Oxford, England)   17 septembre 2020
Outcomes of patients with metastatic castration resistant prostate cancer according to somatic sequencing of domage DNA repair genes.
2020 ASCO Annual Meeting I   25 mai 2020
Sensitization of chondrosarcoma cells with PARP inhibitor and high-LET radiation.
Journal of bone oncology   20 juin 2019